AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 102 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cubist Systematic Strategies, LLC | 18,585 | $191,426 | 0.00% |
| Citadel Advisors | 305,300 | $3,144,590 | 0.00% |
| Qube Research & Technologies Ltd | 53,523 | $551,287 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,912 | $60,893 | 0.00% |
| AMERIPRISE FINANCIAL INC | 285,013 | $2,935,634 | 0.00% |
| GOLDMAN SACHS GROUP INC | 361,452 | $3,722,956 | 0.00% |
| Cetera Advisor Networks LLC | 11,792 | $121,458 | 0.00% |
| JPMORGAN CHASE & CO | 452,472 | $4,660,461 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 318,400 | $3,279,520 | 0.00% |
| Daiwa Securities Group Inc. | 245 | $3 | 0.00% |
| ROYAL BANK OF CANADA | 3,575 | $37,000 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 500 | $5,150 | 0.00% |
| Steward Partners Investment Advisory, LLC | 2,300 | $23,690 | 0.00% |
| Creative Planning | 19,478 | $200,619 | 0.00% |
| HANTZ FINANCIAL SERVICES, INC. | 785 | $8 | 0.00% |
| BARCLAYS PLC | 48 | $0 | 0.00% |
| US BANCORP \DE\ | 18,319 | $188,686 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $10 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 221,867 | $2,285,230 | 0.00% |
| WELLS FARGO & COMPANY/MN | 17,285 | $178,036 | 0.00% |
External links
This page lists AVADEL PHARMACEUTICALS PLC's shareholders in Q3 2023. To view AVADEL PHARMACEUTICALS PLC's shareholder history, click here.